<?xml version="1.0" encoding="UTF-8"?>
<p>Remdesivir is a nucleotide analog that is intracellularly metabolized to triphosphate (
 <xref rid="R18" ref-type="bibr">18</xref>). As well as ebolaviruses, remdesivir inhibits coronaviruses and a range of other viruses (
 <xref rid="R19" ref-type="bibr">19</xref>). It was developed as a substance to treat Ebola infection. It was effective in an experiment on non-human primates, but the results of a clinical trial in patients with Ebola were not convincing. After a preliminary analysis revealed that monoclonal antibodies offered better protection from a fatal outcome, no further patients were treated with remdesivir. The reasons for remdesivirâ€™s poor efficacy against Ebola in this clinical trial remain unexplained (
 <xref rid="R20" ref-type="bibr">20</xref>).
</p>
